Dr. Rasha is a CEO of FADIC. She was in Tanta university hospital, Egypt. In 2013, she received TQM from American university, BCPS, CPHQ, and M.Sc. of Clinical Pharmacy. She received certification from SIDP. She obtained the add qualification from American board in infectious disease. Leaded MM CBAHI Saudi accreditation. Established stewardship committee, and implementation in MCH, Makkah, Saudi Arabia.

She shared in item exam writing for BCIDP Exam. She shared as a reviewer in infectious diseases PSAP. Authorship for published around 20 papers. One paper about vision of 2030 of general pharmaceutical department in Saudi Arabia. She received TLC certification from ACCP academy. Moreover, consultant on personal, professional, stewardship leadership, research. Share in strategic planning; hospital accreditation; and stewardship education.

Dr. Mai received her bachelor’s degree in pharmaceutical sciences in June 2010 from Misr International University in Cairo. She worked as a clinical research associate at Children’s Cancer Hospital from 2012 to 2015. Thereafter, she received a full scholarship from the Fulbright to pursue her master’s degree in Pharmacotherapy and Translational Research which she earned in May 2017 from the University of Florida, U.S. There, she studied the field of pharmacogenomics and personalized medicine and her research work was focused on the role of plasma renin activity biomarker in personalizing the antihypertensive drug therapy. Recently, she received a graduate assistantship from the University of Florida in May 2018 to pursue her PhD in pharmacogenomics and precision medicine.

Pharm.D., Ph.D in Pharmacogenomics
Post-doctoral Associate at University of Florida,
Center of Pharmacogenomics

M.Sc., Graduate Teaching Assistant
Department of Pharmacotherapy,
and Translational Research College of Pharmacy – University of Florida